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Report
Psychomotor stimulants like amphetamine acutely increase locomotor activity.
When these drugs are administered repeatedly in the presence of a particular contextual stimulus complex, long-lasting associations form between the unconditioned effects of the drugs and the contextual stimuli. These associations then allow drugpaired stimuli to elicit drug-like excitatory conditioned responses as in the conditioned locomotion that is observed when rats are returned weeks to months later to the context in which they had previously been administered amphetamine [1] . Given the ubiquity of drug-related stimuli in a contextual stimulus complex previously associated with drug administration, conditioned enhancements in locomotion likely reflect increased approach and interaction with these stimuli [2] , effects characteristic of drug seeking and craving [3] . Indeed, such drug-stimulus associations have been linked to addiction vulnerability and reinstatement in humans and animal models [4] [5] [6] .
Some studies using pharmacological inhibitors have implicated actions of the proline-directed serine/threonine kinase cyclin-dependent kinase 5 (Cdk5) in different brain regions in various types of learning including fear conditioning (lateral septum and hippocampus [7] ) and cocaine conditioned place preference (CPP; basolateral amygdala [BLA;8]). As the major subcortical forebrain projection field of mesolimbic dopamine neurons, the nucleus accumbens (NAcc) has also been found to be an important site of Cdk5 actions in drug conditioning. In an initial report, selective Cdk5 knock-out in the NAcc was found to produce decreased, increased, or no change in the acquisition of cocaine CPP depending on the training dose of cocaine used. This manipulation also spared the acquisition of instrumental responding [9] . However, those results are difficult to interpret as the Cdk5 knock-out manipulation used in that experiment spanned the development and expression phases of conditioning, making it impossible to determine whether the effects observed were due to actions of the Cdk5 knock-out during acquisition, testing, or a combination of the two. Indeed, different neuronal mechanisms appear to underlie the induction and expression of excitatory conditioning [10] [11] and these may be differentially regulated by Cdk5. Recently, we reported that inhibiting Cdk5 signaling in the NAcc exclusively during exposure to amphetamine prevented the accrual of contextual locomotor conditioning by amphetamine, indicating that Cdk5 actions in the NAcc are necessary for the induction of excitatory contextual associative conditioning [12] . In the experiment reported here,
we assessed the effect of inhibiting Cdk5 in the NAcc exclusively on the expression of contextual locomotor conditioning with amphetamine.
Male Sprague-Dawley rats weighing 250-275g on arrival from Harlan (Madison, WI) were housed individually in a reverse cycle room (12-h light/12-h dark, lights on at 8pm). Food and water were freely available at all times. After 4-5 days of acclimation, rats were anesthetized with ketamine (100 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.) and stereotaxically implanted bilaterally with chronic indwelling guide cannula angled at 10 o and aimed at the NAcc shell (A/P, +3.4; M/L, ± 0.8; DV, -7.5mm from bregma and skull).
The NAcc shell was targeted because it has been shown to mediate context-induced drug seeking [13] and is uniquely innervated by the ventral hippocampus [14] , a structure known to possess contextual information [15] . Guide cannulae were fixed in place with dental cement anchored by six screws securely fastened to the skull. [12] refers to the weight of the salt.
Following the 12 days of exposure (4 X 3-day blocks), rats were afforded a 1-week withdrawal period during which they were left undisturbed in their home cages.
Rats in each of the conditioning groups were then randomly assigned to two subgroups that determined whether they received an infusion into the NAcc of vehicle (Veh) or the Cdk5 inhibitor (R)-roscovitine (Ros) prior to the test for conditioning. Six different groups were thus tested on the conditioning test: Paired-Veh, Paired-Ros, Unpaired-Veh, Unpaired-Ros, Control-Veh, and Control-Ros. On the test for conditioned locomotion, rats were administered a systemic saline injection (1.0 ml/kg, i.p.) preceded 30-min earlier by a bilateral infusion into the NAcc of Veh (0.5µl/side) or Ros (40 nmol/0.5µl/side) and their locomotor activity was assessed for 1-hr in the open fields.
Ros (Enzo Life Sciences Inc., Plymouth Meeting, PA) was dissolved in 1XPBS/50% DMSO vehicle. The dose of Ros tested was selected because it has been used by others to study the effects of Cdk5 inhibition in the NAcc (see [16] and references therein). We also recently showed that when infused into the NAcc during drug exposure, this dose of Ros prevents the induction of locomotor conditioning by amphetamine [12] . The use of the same dose in the present study assessing the effects of inhibiting NAcc Cdk5 on the expression of locomotor conditioning will thus allow the direct comparison of the results obtained to those obtained in our recent study [12] as well as those reported by others (see [16] ).
After the conditioning test, rats were deeply anesthetized with ketamine and xylazine and subjected to intracardiac perfusion with 0.9% saline followed by 10% formalin. Brains were then harvested, stored in 10% formalin, and 40 µm coronal slices taken with a cryostat. Brain slices were mounted onto gelatin-coated slides and subsequently stained with a cresyl violet solution in order to verify cannula tip placements within the NAcc shell. Only rats with bilateral cannula tips placed correctly within the NAcc shell were included in the behavioral analyses ( Figure 2B) . Of the 50 rats tested, 15 rats failed to meet this histological criterion and were thus excluded.
As expected, Paired rats administered amphetamine in the open fields displayed greater locomotor activation throughout the drug exposure phase compared to Unpaired and Control rats administered saline (Figure 1 ). This was true whether rats were subsequently designated Ros or Veh, as Ros was not administered during this phase.
The one-way between one-way within repeated measures ANOVA conducted on the 2- proposed to account for the ability of Cdk5 inhibition in the NAcc to enhance the expression of cocaine-induced locomotor sensitization and incentive to self-administer the drug [16] . In these studies, evidence for a potential underlying mechanism was obtained by which repeated exposure to cocaine increased striatal levels of Cdk5 mRNA, leading to increased Cdk5 phosphorylation of DARPP-32 at Thr 75, and thereby decreasing phosphorylation by PKA of DARPP-32 at Thr 34. This pathway results in less protein phosphatase (PP1) inhibition and decreased phosphorylation of proteins responsible for psychostimulant induced locomotion [16] [17] . Thus, inhibiting Cdk5 in the NAcc would lead to increased PP1 inhibition, greater phosphorylation of target proteins, and greater locomotor output. Such a sequence of neuronal events could potentially also provide a mechanism for the present results showing that inhibiting NAcc Cdk5 enhances the expression of conditioned locomotion. However, the signaling pathway by which a drug-paired stimulus complex might recruit NAcc Cdk5 to constrain the expression of conditioned locomotion remains to be determined. Interestingly, increased Cdk5 activity and levels of the Cdk5 activator p35 have been observed in the BLA of rats displaying a CPP for a cocaine associated context on a drug-free test, although in that study, infusion into the BLA of a dose of β-butyrolactone known to inhibit Cdk5 blocked rather than enhanced the expression of the CPP (see [8] and references therein). These findings together with those reported here clearly highlight important differences in the effects of Cdk5 in the NAcc and the BLA on the expression of excitatory conditioned drug effects. It will be important to determine whether drug-paired stimuli can alter Cdk5 activity in the NAcc and delineate how downstream signaling is affected in this site.
In addition to inhibiting Cdk5, Ros has also been shown to produce other effects with lower potency, including slowing of the deactivation of N-type calcium channels [18] and increasing dopamine overflow in vitro [19] , effects that could also enhance behavioral responding to psychostimulants [20] [21] . In these cases as well, however, it remains to be determined by which signaling pathway these effects might have selectively modulated the expression of conditioned locomotion in the present experiment as no detectible effects of NAcc-Ros were observed in Unpaired and Control rats.
Interestingly, the enhancement of the conditioned locomotion expressed in the present experiment when NAcc-Ros was administered exclusively on the test for conditioning differs remarkably from what we observed previously when NAcc-Ros was administered exclusively during the amphetamine-open-field pairings and inhibited the development of conditioned locomotion [12] . Together, these findings clearly indicate different roles for NAcc Cdk5 in the induction and expression of excitatory conditioning by amphetamine that likely reflect different actions of the enzyme. As with sensitization [21] , different neuronal mechanisms have been proposed to underlie the development and expression of excitatory conditioning [10] [11] . The present results suggest that these are modulated differently by Cdk5. This enzyme may contribute to the induction of excitatory drug conditioning by regulating spine maturity [22] and the capacity of spines for rapid morphological change upon the presentation of drug-paired stimuli [12, 23] .
Importantly, these different actions of Cdk5 require that caution be exercised when interpreting the results of a number of recent reports using knock-out, knock-down or transgenic mouse preparations to manipulate Cdk5 signaling [9, 24, 25] 
